These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9880385)

  • 41. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group.
    Jaillard A; Cornu C; Durieux A; Moulin T; Boutitie F; Lees KR; Hommel M
    Stroke; 1999 Jul; 30(7):1326-32. PubMed ID: 10390303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.
    Patel SC; Levine SR; Tilley BC; Grotta JC; Lu M; Frankel M; Haley EC; Brott TG; Broderick JP; Horowitz S; Lyden PD; Lewandowski CA; Marler JR; Welch KM;
    JAMA; 2001 Dec; 286(22):2830-8. PubMed ID: 11735758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced pretreatment ipsilateral middle cerebral artery cerebral blood flow is predictive of symptomatic hemorrhage post-intra-arterial thrombolysis in patients with middle cerebral artery occlusion.
    Gupta R; Yonas H; Gebel J; Goldstein S; Horowitz M; Grahovac SZ; Wechsler LR; Hammer MD; Uchino K; Jovin TG
    Stroke; 2006 Oct; 37(10):2526-30. PubMed ID: 16960093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy.
    Leigh R; Zaidat OO; Suri MF; Lynch G; Sundararajan S; Sunshine JL; Tarr R; Selman W; Landis DM; Suarez JI
    Stroke; 2004 Aug; 35(8):1903-7. PubMed ID: 15178819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
    Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
    Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage.
    Tsivgoulis G; Frey JL; Flaster M; Sharma VK; Lao AY; Hoover SL; Liu W; Stamboulis E; Alexandrov AW; Malkoff MD; Alexandrov AV
    Stroke; 2009 Nov; 40(11):3631-4. PubMed ID: 19762689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
    Lin TC; Chao TH; Shieh Y; Lee TH; Chang YJ; Lee JD; Peng TI; Chang KC; Liou CW; Chang TY; Hung KL; Chang CH
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e455-62. PubMed ID: 23800497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?
    Agarwal P; Kumar S; Hariharan S; Eshkar N; Verro P; Cohen B; Sen S
    Cerebrovasc Dis; 2004; 17(2-3):182-90. PubMed ID: 14707420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study.
    Larrue V; von Kummer R; del Zoppo G; Bluhmki E
    Stroke; 1997 May; 28(5):957-60. PubMed ID: 9158632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Response of blood pressure and blood glucose to treatment with recombinant tissue-type plasminogen activator in acute ischemic stroke: evidence from the virtual international stroke trials archive.
    Kerr DM; Fulton RL; Higgins P; Bath PM; Shuaib A; Lyden P; Lees KR;
    Stroke; 2012 Feb; 43(2):399-404. PubMed ID: 22075999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis.
    Bang OY; Saver JL; Liebeskind DS; Starkman S; Villablanca P; Salamon N; Buck B; Ali L; Restrepo L; Vinuela F; Duckwiler G; Jahan R; Razinia T; Ovbiagele B
    Neurology; 2007 Mar; 68(10):737-42. PubMed ID: 17182976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
    Charidimou A; Pasi M; Fiorelli M; Shams S; von Kummer R; Pantoni L; Rost N
    Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neutrophil-to-Lymphocyte Ratio and Response to Intravenous Thrombolysis in Patients with Acute Ischemic Stroke.
    Pektezel MY; Yilmaz E; Arsava EM; Topcuoglu MA
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1853-1859. PubMed ID: 31072698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke.
    Mokin M; Kass-Hout T; Kass-Hout O; Zivadinov R; Mehta B
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):852-9. PubMed ID: 21703878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
    Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
    Horsch AD; Bennink E; van Seeters T; Kappelle LJ; van der Graaf Y; Mali WPTM; de Jong HWAM; Velthuis BK; Dankbaar JW;
    Cerebrovasc Dis; 2018; 45(1-2):26-32. PubMed ID: 29402765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The presence of a right-to-left shunt is associated with dramatic improvement after thrombolytic therapy in patients with acute ischemic stroke.
    Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Aoki J; Matsumoto N
    Stroke; 2009 Jan; 40(1):303-5. PubMed ID: 18845803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
    Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
    Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator.
    Menon BK; Saver JL; Prabhakaran S; Reeves M; Liang L; Olson DM; Peterson ED; Hernandez AF; Fonarow GC; Schwamm LH; Smith EE
    Stroke; 2012 Sep; 43(9):2293-9. PubMed ID: 22811458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.